128940.KS Earnings — Hanmi Pharm. Co., Ltd.
KSC
Updated
When is 128940.KS's next earnings date?
Hanmi Pharm. Co., Ltd. (128940.KS) has not announced its next earnings date yet. Its most recent earnings report was on Tuesday, October 27, 2026.
How did 128940.KS do in its last earnings report?
In its most recent report on Oct 27, 2026, Hanmi Pharm. Co., Ltd. posted EPS of $954.96 versus the $3207.00 estimate, a miss. Revenue was $377.40B against a $413.17B estimate.
How much does 128940.KS stock move after earnings?
128940.KS beat EPS estimates in 1 of its last 2 reported quarters.
About Hanmi Pharm. Co., Ltd.
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
🤖 AI Earnings Analysis
Revenue of $370.5B missed the $414.0B consensus by 10.5%, a clear top-line disappointment. With no usable EPS, growth, or catalyst data, the result points to a weak quarter.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | 3207.00 | 954.96 | — | $377.40B | ❌ Miss | — | — | — | |
| 2026-07-28 | 4062.00 | 6566.00 | — | $467.20B | ✅ Beat | — | — | — |
Showing last 2 quarters.